Know Cancer

or
forgot password

Quality of Life Analysis of Prostate Cancer Patient's Therapy


N/A
N/A
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Quality of Life Analysis of Prostate Cancer Patient's Therapy


Inclusion Criteria:



- Provision of informed consent

- Early or locally-advanced prostate cancer patients on androgen deprivation therapy

- Investigators are requested to recruit patients only with at least 1 month prior
Zoladex treatment.

Exclusion Criteria:

- Allergy to substance of medication

- Prostate cancer patients with advanced disease

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Elements of a general and three disease-specific investigator questionnaire

Outcome Time Frame:

Quarterly (plus or minus 3 days )

Safety Issue:

No

Principal Investigator

P├ęter Tenke, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

"Jahn Ferenc" City Hospital Budapest

Authority:

Hungary: National Institute of Pharmacy

Study ID:

NIS-OHU-ZOL-2007/1

NCT ID:

NCT00692874

Start Date:

June 2008

Completion Date:

September 2010

Related Keywords:

  • Prostate Cancer
  • Quality of Life
  • Prostatic Neoplasms

Name

Location